By vgreene, 8 September, 2015 Recommend breast awareness (ACS,1 ACOG,9 NCCN11). If BRCA(+): Start breast awareness @ 18 yo, per NCCN12
By vgreene, 8 September, 2015 BSE results in more bx and benign lesion dx, per NCI.17 However, ACOG9 recommends BSE instruction for BRCA(+) pts, pts w/ confirmed BRCA/other gene mutation in 1st-deg relative, or pts w/ lifetime risk ≥20% based on FHx model
By vgreene, 8 September, 2015 If hx chest RT: clinical encounter14 starting 8-10y after RT; annually, if current age
By vgreene, 8 September, 2015 If ≥20% lifetime risk per FHx-based tool: Recommend clinical encounter14 q6-12mo starting from when increased risk first identified, but not before 21 yo (NCCN11); ACOG9,15 recommends q6mo
By vgreene, 8 September, 2015 If lifetime risk1,2 ≥20% or hx chest radiation tx when 10-30 yo: MRI + mammography screen (tomosynthesis guidance varies)
By vgreene, 8 September, 2015 Stop screening: Continue as long as pt in good health (ACS7) and life expectancy exceeds 5-7y (ACR13)